Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

• Josep M. Llibre ,

  * E-mail: jmllibre@flsida.org

  Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• Isabel Bravo,

  Affiliation HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Arelly Ornelas,

  Affiliation Department of Econometrics, Statistics and Economy, University of Barcelona, Barcelona, Spain

  ⨯
• José R. Santos,

  Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain

  ⨯
• Jordi Puig,

  Affiliation HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain

  ⨯
• Raquel Martin-Iguacel,

  Affiliation Infectious Diseases Dept, Odense University Hospital, Odense, Denmark

  ⨯
• Roger Paredes,

  Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain, Universitat de Vic (UVic). Vic, Catalonia, Spain

  ⨯
• Bonaventura Clotet

  Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain, Universitat de Vic (UVic). Vic, Catalonia, Spain

  ⨯